- Home
- BHE vs OCUL Comparison
BHE vs OCUL Comparison
Compare BHE & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHE | OCUL |
|---|---|---|
| Founded | 1979 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BHE | OCUL |
|---|---|---|
| Price | $83.20 | $8.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $55.00 | $23.56 |
| AVG Volume (30 Days) | 435.7K | ★ 2.6M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $2,659,108,000.00 | $1,990,000.00 |
| Revenue This Year | $7.03 | $7.93 |
| Revenue Next Year | $6.57 | $96.07 |
| P/E Ratio | $230.65 | ★ N/A |
| Revenue Growth | 0.11 | ★ 3.48 |
| 52 Week Low | $34.44 | $6.23 |
| 52 Week High | $87.73 | $16.44 |
Technical Indicators
Market Signals| Indicator | BHE | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 36.27 |
| Support Level | $39.25 | $7.38 |
| Resistance Level | $87.73 | $9.93 |
| Average True Range (ATR) | 3.92 | 0.44 |
| MACD | -0.69 | -0.15 |
| Stochastic Oscillator | 62.15 | 1.73 |
Price Performance
Historical ComparisonAbout BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.